The German government is facing awkward questions about why the country that developed the first approved Covid-19 vaccine has so few supplies of the jab, with vaccination rates in Germany lagging far behind the US, UK and Israel.
德国政府正面临一个尴尬的问题：作为研发出首款获得批准的新冠疫苗的国家，为什么德国的新冠疫苗供应量如此之少？德国的新冠疫苗接种率远远落后于美国、英国和以色列。
您已阅读6%（308字），剩余94%（4627字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。